If BIEL does a 10 for 1 r/s that would bring o/s down from 7 billion to 700 million. Then 12 months later another it can do another 10x1 r/s to bring it down to 70 million shares outstanding. If this bust out over a penny with FDA product approval then it would be over a dollar a share eligible to get off picks to higher exchange. I will be interested in August 15 financials to see if it is even possible. If so with world wide distribution of Actipatch and their other products this could be a great long term play for profit. Comments?